“Oral amoxicillin versus intravenous ampicillin for chest indrawing pneumonia in children aged 3–59 months: A randomized control trial” (2020) Indian Journal of Child Health, 7(8), pp. 332–336. doi:10.32677/IJCH.2020.v07.i08.003.